Molecular ligand-receptor interaction of the NPY/PP peptide family

  • Nicole Merten
  • Annette G. Beck-Sickinger
Part of the Experientia Supplementum book series (EXS, volume 95)


Pancreatic Polypeptide Peptide Ligand Peptide Family Human Neuroblastoma Cell Line Bioluminescence Resonance Energy Transfer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Seidah NG, Chretien M (1999) Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848: 45–62CrossRefPubMedGoogle Scholar
  2. 2.
    Steiner DF (1998) The proprotein convertases. Curr Opin Chem Biol 2: 31–39CrossRefPubMedGoogle Scholar
  3. 3.
    Kimmel JR, Pollock HG, Hazelwood RL (1968) Isolation and characterization of chicken insulin. Endocrinology 83: 1323–1330PubMedGoogle Scholar
  4. 4.
    Kimmel JR, Hayden LJ, Pollock HG (1975) Isolation and characterization of a new pancreatic polypeptide hormone. J Biol Chem 250: 9369–9376PubMedGoogle Scholar
  5. 5.
    Larhammar D (1996) Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 62: 1–11CrossRefPubMedGoogle Scholar
  6. 6.
    Conlon JM (2002) The origin and evolution of peptide YY (PYY) and pancreatic polypeptide (PP). Peptides 23: 269–278PubMedGoogle Scholar
  7. 7.
    Hazelwood RL (1993) The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 202: 44–63PubMedGoogle Scholar
  8. 8.
    Schwartz TW, Rehfeld JF, Stadil F, Larson LI, Chance RE, Moon N (1976) Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet 1: 1102–1105PubMedGoogle Scholar
  9. 9.
    Nussdorfer GG, Mazzocchi G, Malendowicz LK (1998) The possible involvement of pancreatic polypeptide in the paracrine regulation of human and rat adrenal cortex. Endocr Res 24: 695–702PubMedGoogle Scholar
  10. 10.
    Tatemoto K, Mutt V (1980) Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285: 417–418CrossRefPubMedGoogle Scholar
  11. 11.
    Tatemoto K (1982) Isolation and characterization of peptide YY (PYY), a candidate gut hormonee that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 79: 2514–2518PubMedGoogle Scholar
  12. 12.
    Ekblad E, Sundler F (2002) Distribution of pancreatic polypeptide and peptide YY. Peptides 23: 251–261CrossRefPubMedGoogle Scholar
  13. 13.
    Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y — a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659–660CrossRefPubMedGoogle Scholar
  14. 14.
    Tatemoto K (1982) Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79: 5485–5489PubMedGoogle Scholar
  15. 15.
    Larhammar D, Blomqvist AG, Soderberg C (1993) Evolution of neuropeptide Y and its related peptides. Comp Biochem Physiol C 106: 743–752PubMedGoogle Scholar
  16. 16.
    Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O’Donohue TL (1985) The anatomy of neuropeptide Y-containing neurons in rat brain. Neuroscience 15: 1159–1181CrossRefPubMedGoogle Scholar
  17. 17.
    Lecklin A, Lundell I, Paananen L, Wikberg JE, Mannisto PT, Larhammar D (2002) Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig. Br J Pharmacol 135: 2029–2037CrossRefPubMedGoogle Scholar
  18. 18.
    Nakajima M, Inui A, Teranishi A, Miura M, Hirosue Y, Okita M, Himori N, Baba S, Kasuga M (1994) Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. J Pharmacol Exp Ther 268: 1010–1014PubMedGoogle Scholar
  19. 19.
    Pau MY, Pau KY, Spies HG (1988) Characterization of central actions of neuropeptide Y on food and water intake in rabbits. Physiol Behav 44: 797–802CrossRefPubMedGoogle Scholar
  20. 20.
    Lopez-Valpuesta FJ, Nyce JW, Griffin-Biggs TA, Ice JC, Myers RD (1996) Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats. Proc R Soc Lond B Biol Sci 263: 881–886Google Scholar
  21. 21.
    Cleary J, Semotuk M, Levine AS (1994) Effects of neuropeptide Y on short-term memory. Brain Res 653: 210–214CrossRefPubMedGoogle Scholar
  22. 22.
    Kalra SP, Xu B, Dube MG, Moldawer LL, Martin D, Kalra PS (1998) Leptin and ciliary neurotropic factor (CNTF) inhibit fasting-induced suppression of luteinizing hormone release in rats: role of neuropeptide Y. Neurosci Lett 240: 45–49CrossRefPubMedGoogle Scholar
  23. 23.
    McDonald JK (1988) NPY and related substances. Crit Rev Neurobiol 4: 97–135PubMedGoogle Scholar
  24. 24.
    Pernow J, Ohlen A, Hokfelt T, Nilsson O, Lundberg JM (1987) Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. Regul Pept 19: 313–324CrossRefPubMedGoogle Scholar
  25. 25.
    Maturi MF, Greene R, Speir E, Burrus C, Dorsey LM, Markle DR, Maxwell M, Schmidt W, Goldstein SR, Patterson RE (1989) Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs. J Clin Invest 83: 1217–1224PubMedGoogle Scholar
  26. 26.
    Ahlborg G, Weitzberg E, Lundberg JM (1992) Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans. Clin Physiol 12: 145–153PubMedGoogle Scholar
  27. 27.
    Edvinsson L, Emson P, McCulloch J, Tatemoto K, Uddman R (1984) Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand 122: 155–163PubMedGoogle Scholar
  28. 28.
    Cerda-Reverter JM, Larhammar D (2000) Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution. Biochem Cell Biol 78: 371–392PubMedGoogle Scholar
  29. 29.
    Fuhlendorff J, Johansen NL, Melberg SG, Thogersen H, Schwartz TW (1990) The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors. J Biol Chem 265: 11706–11712PubMedGoogle Scholar
  30. 30.
    Blundell TL, Pitts JE, Tickle IJ, Wood SP (1981) The conformation and receptor binding of pancreatic hormones. Biochem Soc Trans 9: 31–32PubMedGoogle Scholar
  31. 31.
    Cowley DJ, Hoflack JM, Pelton JT, Saudek V (1992) Structure of neuropeptide Y dimer in solution. Eur J Biochem 205: 1099–1106CrossRefPubMedGoogle Scholar
  32. 32.
    Darbon H, Bernassau JM, Deleuze C, Chenu J, Roussel A, Cambillau C (1992) Solution conformation of human neuropeptide Y by 1H nuclear magnetic resonance and restrained molecular dynamics. Eur J Biochem 209: 765–771CrossRefPubMedGoogle Scholar
  33. 33.
    Glover I, Haneef I, Pitts J, Wood S, Moss D, Tickle I, Blundell T (1983) Conformational flexibility in a small globular hormone: x-ray analysis of avian pancreatic polypeptide at 0.98-A resolution. Biopolymers 22: 293–304CrossRefPubMedGoogle Scholar
  34. 34.
    Nordmann A, Blommers MJ, Fretz H, Arvinte T, Drake AF (1999) Aspects of the molecular structure and dynamics of neuropeptide Y. Eur J Biochem 261: 216–226CrossRefPubMedGoogle Scholar
  35. 35.
    Bader R, Bettio A, Beck-Sickinger AG, Zerbe O (2001) Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. J Mol Biol 305: 307–329CrossRefPubMedGoogle Scholar
  36. 36.
    Bettio A, Dinger MC, Beck-Sickinger AG (2002) The neuropeptide Y monomer in solution is not folded in the pancreatic-polypeptide fold. Protein Sci 11: 1834–1844CrossRefPubMedGoogle Scholar
  37. 37.
    Bettio A, Gutewort V, Poppl A, Dinger MC, Zschornig O, Klaus A, Toniolo C, Beck-Sickinger AG (2002) Electron paramagnetic resonance backbone dynamics studies on spin-labelled neuropeptide Y analogues. J Pept Sci 8: 671–682PubMedGoogle Scholar
  38. 38.
    Larhammar D, Wraith A, Berglund MM, Holmberg SK, Lundell I (2001) Origins of the many NPY-family receptors in mammals. Peptides 22: 295–307CrossRefPubMedGoogle Scholar
  39. 39.
    Weinberg DH, Sirinathsinghji DJ, Tan CP, Shiao LL, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne ML, Cascieri MA et al. (1996) Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271: 16435–16438PubMedGoogle Scholar
  40. 40.
    Matsumoto M, Nomura T, Momose K, Ikeda Y, Kondou Y, Akiho H, Togami J, Kimura Y, Okada M, Yamaguchi T (1996) Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 271: 27217–27220PubMedGoogle Scholar
  41. 41.
    Gregor P, Feng Y, DeCarr LB, Cornfield LJ, McCaleb ML (1996) Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J Biol Chem 271: 27776–27781PubMedGoogle Scholar
  42. 42.
    Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA (1992) Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89: 5794–5798PubMedGoogle Scholar
  43. 43.
    Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlested C (1992) Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267: 10935–10938PubMedGoogle Scholar
  44. 44.
    Gordon EA, Kohout TA, Fishman PH (1990) Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line. J Neurochem 55: 506–513PubMedGoogle Scholar
  45. 45.
    Misra S, Murthy KS, Zhou H, Grider JR (2004) Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways. J Pharmacol Exp Ther 311: 1154–1162CrossRefPubMedGoogle Scholar
  46. 46.
    Hinson J, Rauh C, Coupet J (1988) Neuropeptide Y stimulates inositol phospholipid hydrolysis in rat brain miniprisms. Brain Res 446: 379–382CrossRefPubMedGoogle Scholar
  47. 47.
    Aakerlund L, Gether U, Fuhlendorff J, Schwartz TW, Thastrup O (1990) Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Lett 260: 73–78CrossRefPubMedGoogle Scholar
  48. 48.
    Mannon PJ, Mele JM (2000) Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor. Biochem J 350 Pt 3: 655–661CrossRefPubMedGoogle Scholar
  49. 49.
    Xiong Z, Cheung DW (1995) ATP-dependent inhibition of Ca2+-activated K+ channels in vascular smooth muscle cells by neuropeptide Y. Pflugers Arch 431: 110–116CrossRefPubMedGoogle Scholar
  50. 50.
    Ewald DA, Sternweis PC, Miller RJ (1988) Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons. Proc Natl Acad Sci USA 85: 3633–3637PubMedGoogle Scholar
  51. 51.
    Lemos VS, Takeda K (1995) Neuropeptide Y2-type receptor-mediated activation of large-conductance Ca(2+)-sensitive K+ channels in a human neuroblastoma cell line. Pflugers Arch 430: 534–540CrossRefPubMedGoogle Scholar
  52. 52.
    Eva C, Keinanen K, Monyer H, Seeburg P, Sprengel R (1990) Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett 271: 81–84CrossRefPubMedGoogle Scholar
  53. 53.
    Ball HJ, Shine J, Herzog H (1995) Multiple promoters regulate tissue-specific expression of the human NPY-Y1 receptor gene. J Biol Chem 270: 27272–27276PubMedGoogle Scholar
  54. 54.
    Marklund U, Bystrom M, Gedda K, Larefalk A, Juneblad K, Nystrom S, Ekstrand AJ (2002) Intron-mediated expression of the human neuropeptide Y Y1 receptor. Mol Cell Endocrinol 188: 85–97CrossRefPubMedGoogle Scholar
  55. 55.
    Grundemar L, Jonas SE, Morner N, Hogestatt ED, Wahlestedt C, Hakanson R (1992) Characterization of vascular neuropeptide Y receptors. Br J Pharmacol 105: 45–50PubMedGoogle Scholar
  56. 56.
    Wahlestedt C, Grundemar L, Hakanson R, Heilig M, Shen GH, Zukowska-Grojec Z, Reis DJ (1990) Neuropeptide Y receptor subtypes, Y1 and Y2. Ann NY Acad Sci 611: 7–26PubMedGoogle Scholar
  57. 57.
    Potter EK, Mitchell L, McCloskey MJ, Tseng A, Goodman AE, Shine J, McCloskey DI (1989) Pre-and postjunctional actions of neuropeptide Y and related peptides. Regul Pept 25: 167–177CrossRefPubMedGoogle Scholar
  58. 58.
    Dumont Y, Fournier A, St-Pierre S, Schwartz TW, Quirion R (1990) Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain. Eur J Pharmacol 191: 501–503CrossRefPubMedGoogle Scholar
  59. 59.
    Aicher SA, Springston M, Berger SB, Reis DJ, Wahlestedt C (1991) Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain. Neurosci Lett 130: 32–36CrossRefPubMedGoogle Scholar
  60. 60.
    Mannon PJ, Mervin SJ, Sheriff-Carter KD (1994) Characterization of a Y1-preferring NPY/PYY receptor in HT-29 cells. Am J Physiol 267: G901–907PubMedGoogle Scholar
  61. 61.
    Castan I, Valet P, Larrouy D, Voisin T, Remaury A, Daviaud D, Laburthe M, Lafontan M (1993) Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system. Am J Physiol 265: E74–80PubMedGoogle Scholar
  62. 62.
    Grundemar L, Ekelund M (1996) Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements. Pharmacol Toxicol 79: 266–269PubMedGoogle Scholar
  63. 63.
    Abrahamsson C (2000) Neuropeptide Y1-and Y2-receptor-mediated cardiovascular effects in the anesthetized guinea pig, rat, and rabbit. J Cardiovasc Pharmacol 36: 451–458PubMedGoogle Scholar
  64. 64.
    Capurro D, Huidobro-Toro JP (1999) The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304. Eur J Pharmacol 376: 251–255CrossRefPubMedGoogle Scholar
  65. 65.
    Zhang Y, Lundeberg T, Yu L (2000) Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats. Regul Pept 95: 109–113CrossRefPubMedGoogle Scholar
  66. 66.
    Naveilhan P, Hassani H, Lucas G, Blakeman KH, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Thoren P, Ernfors P (2001) Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 409: 513–517CrossRefPubMedGoogle Scholar
  67. 67.
    Wieland HA, Engel W, Eberlein W, Rudolf K, Doods HN (1998) Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br J Pharmacol 125: 549–555CrossRefPubMedGoogle Scholar
  68. 68.
    Kask A, Rago L, Harro J (1998) Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226. Br J Pharmacol 124: 1507–1515CrossRefPubMedGoogle Scholar
  69. 69.
    Kanatani A, Ito J, Ishihara A, Iwaasa H, Fukuroda T, Fukami T, MacNeil DJ, Van der Ploeg LH, Ihara M (1998) NPY-induced feeding involves the action of a Y1-like receptor in rodents. Regul Pept 75–76: 409–415PubMedGoogle Scholar
  70. 70.
    Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993) Modulation of anxiety and neuropeptide Y–Y1 receptors by antisense oligodeoxynucleotides. Science 259: 528–531PubMedGoogle Scholar
  71. 71.
    Caberlotto L, Jimenez P, Overstreet DH, Hurd YL, Mathe AA, Fuxe K (1999) Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression. Neurosci Lett 265: 191–194CrossRefPubMedGoogle Scholar
  72. 72.
    Kelley SP, Nannini MA, Bratt AM, Hodge CW (2001) Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration. Peptides 22: 515–522CrossRefPubMedGoogle Scholar
  73. 73.
    Thiele TE, Koh MT, Pedrazzini T (2002) Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J Neurosci 22: RC208PubMedGoogle Scholar
  74. 74.
    Parker SL, Kane JK, Parker MS, Berglund MM, Lundell IA, Li MD (2001) Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur J Biochem 268: 877–886CrossRefPubMedGoogle Scholar
  75. 75.
    Fabry M, Langer M, Rothen-Rutishauser B, Wunderli-Allenspach H, Hocker H, Beck-Sickinger AG (2000) Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-NMC. Eur J Biochem 267: 5631–5637CrossRefPubMedGoogle Scholar
  76. 76.
    Gicquiaux H, Lecat S, Gaire M, Dieterlen A, Mely Y, Takeda K, Bucher B, Galzi JL (2002) Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J Biol Chem 277: 6645–6655CrossRefPubMedGoogle Scholar
  77. 77.
    Berglund MM, Schober DA, Statnick MA, McDonald PH, Gehlert DR (2003) The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced betaarrestin 2 interaction. J Pharmacol Exp Ther 306: 147–156CrossRefPubMedGoogle Scholar
  78. 78.
    Fuhlendorff J, Gether U, Aakerlund L, Langeland-Johansen N, Thogersen H, Melberg SG, Olsen UB, Thastrup O, Schwartz TW (1990) [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci USA 87: 182–186PubMedGoogle Scholar
  79. 79.
    Sheikh SP, O’Hare MM, Tortora O, Schwartz TW (1989) Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines. J Biol Chem 264: 6648–6654PubMedGoogle Scholar
  80. 80.
    Michel MC, Schlicker E, Fink K, Boublik JH, Gothert M, Willette RN, Daly RN, Hieble JP, Rivier JE, Motulsky HJ (1990) Distinction of NPY receptors in vitro and in vivo. I. NPY-(18–36) discriminates NPY receptor subtypes in vitro. Am J Physiol 259: E131–139PubMedGoogle Scholar
  81. 81.
    Feth F, Rascher W, Michel MC (1992) Neuropeptide Y (NPY) receptors in HEL cells: comparison of binding and functional parameters for full and partial agonists and a non-peptide antagonist. Br J Pharmacol 105: 71–76PubMedGoogle Scholar
  82. 82.
    Schwartz TW, Sheikh SP, O’Hare MM (1987) Receptors on phaeochromocytoma cells for two members of the PP-fold family-NPY and PP. FEBS Lett 225: 209–214CrossRefPubMedGoogle Scholar
  83. 83.
    Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B, Seethala R (1995) Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270: 22661–22664PubMedGoogle Scholar
  84. 84.
    Grouzmann E, Buclin T, Martire M, Cannizzaro C, Dorner B, Razaname A, Mutter M (1997) Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist. J Biol Chem 272: 7699–7706PubMedGoogle Scholar
  85. 85.
    Hofliger MM, Castejon GL, Kiess W, Beck Sickinger AG (2003) Novel cell line selectively expressing neuropeptide Y–Y2 receptors. J Recept Signal Transduct Res 23: 351–360PubMedGoogle Scholar
  86. 86.
    Lynch JW, Lemos VS, Bucher B, Stoclet JC, Takeda K (1994) A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y2 receptors in a human neuroblastoma cell line. J Biol Chem 269: 8226–8233PubMedGoogle Scholar
  87. 87.
    Malmstrom RE, Hokfelt T, Bjorkman JA, Nihlen C, Bystrom M, Ekstrand AJ, Lundberg JM (1998) Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. Regul Pept 75–76: 55–70PubMedGoogle Scholar
  88. 88.
    Gerald C, Walker MW, Vaysse PJ, He C, Branchek TA, Weinshank RL (1995) Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem 270: 26758–26761PubMedGoogle Scholar
  89. 89.
    Gehlert DR, Beavers LS, Johnson D, Gackenheimer SL, Schober DA, Gadski RA (1996) Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol Pharmacol 49: 224–228PubMedGoogle Scholar
  90. 90.
    Sharma P, Holmberg SK, Eriksson H, Beck-Sickinger AG, Grundemar L, Larhammar D (1998) Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor. Regul Pept 75–76: 23–28PubMedGoogle Scholar
  91. 91.
    Salaneck E, Holmberg SK, Berglund MM, Boswell T, Larhammar D (2000) Chicken neuropeptide Y receptor Y2: structural and pharmacological differences to mammalian Y2(1). FEBS Lett 484: 229–234CrossRefPubMedGoogle Scholar
  92. 92.
    Stjernquist M, Owman C (1990) Further evidence for a prejunctional action of neuropeptide Y on cholinergic motor neurons in the rat uterine cervix. Acta Physiol Scand 138: 95–96PubMedGoogle Scholar
  93. 93.
    Wahlestedt C, Hakanson R (1986) Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre-and postjunctional receptors be distinguished? Med Biol 64: 85–88PubMedGoogle Scholar
  94. 94.
    Gehlert DR, Gackenheimer SL, Schober DA (1992) [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain. Neurochem Int 21: 45–67PubMedGoogle Scholar
  95. 95.
    Dumont Y, Fournier A, St-Pierre S, Quirion R (1993) Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci 13: 73–86PubMedGoogle Scholar
  96. 96.
    Rettenbacher M, Reubi JC (2001) Localization and characterization of neuropeptide receptors in human colon. Naunyn Schmiedebergs Arch Pharmacol 364: 291–304CrossRefPubMedGoogle Scholar
  97. 97.
    Flood JF, Morley JE (1989) Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre-and postsynaptic mediation. Peptides 10: 963–966PubMedGoogle Scholar
  98. 98.
    Wahlestedt C, Yanaihara N, Hakanson R (1986) Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13: 307–318CrossRefPubMedGoogle Scholar
  99. 99.
    Nakajima M, Inui A, Asakawa A, Momose K, Ueno N, Teranishi A, Baba S, Kasuga M (1998) Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 19: 359–363CrossRefPubMedGoogle Scholar
  100. 100.
    Sajdyk TJ, Schober DA, Smiley DL, Gehlert DR (2002) Neuropeptide Y–Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 71: 419–423CrossRefPubMedGoogle Scholar
  101. 101.
    Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E et al. (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83: 187–195PubMedGoogle Scholar
  102. 102.
    Gribkoff VK, Pieschl RL, Wisialowski TA, van den Pol AN, Yocca FD (1998) Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes. J Neurosci 18: 3014–3022PubMedGoogle Scholar
  103. 103.
    Golombek DA, Biello SM, Rendon RA, Harrington ME (1996) Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor. Neuroreport 7: 1315–1319PubMedGoogle Scholar
  104. 104.
    Gehlert DR (1998) Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc Soc Exp Biol Med 218: 7–22PubMedGoogle Scholar
  105. 105.
    Lee CC, Miller RJ (1998) Is there really an NPY Y3 receptor? Regul Pept 75–76: 71–78PubMedGoogle Scholar
  106. 106.
    Cavadas C, Silva AP, Mosimann F, Cotrim MD, Ribeiro CA, Brunner HR, Grouzmann E (2001) NPY regulates catecholamine secretion from human adrenal chromaffin cells. J Clin Endocrinol Metab 86: 5956–5963CrossRefPubMedGoogle Scholar
  107. 107.
    Balasubramaniam A, Sheriff S, Rigel DF, Fischer JE (1990) Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes. Peptides 11: 545–550PubMedGoogle Scholar
  108. 108.
    Wahlestedt C, Regunathan S, Reis DJ (1992) Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci 50: PL7–12CrossRefPubMedGoogle Scholar
  109. 109.
    Dumont Y, Satoh H, Cadieux A, Taoudi-Benchekroun M, Pheng LH, St-Pierre S, Fournier A, Quirion R (1993) Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types. Eur J Pharmacol 238: 37–45CrossRefPubMedGoogle Scholar
  110. 110.
    Norenberg W, Bek M, Limberger N, Takeda K, Illes P (1995) Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system. Naunyn Schmiedebergs Arch Pharmacol 351: 337–347PubMedGoogle Scholar
  111. 111.
    Grundemar L, Wahlestedt C, Reis DJ (1991) Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J Pharmacol Exp Ther 258: 633–638PubMedGoogle Scholar
  112. 112.
    Lundell I, Blomqvist AG, Berglund MM, Schober DA, Johnson D, Statnick MA, Gadski RA, Gehlert DR, Larhammar D (1995) Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 270: 29123–29128PubMedGoogle Scholar
  113. 113.
    Bard JA, Walker MW, Branchek TA, Weinshank RL (1995) Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 270: 26762–26765PubMedGoogle Scholar
  114. 114.
    Ledeboer M, Masclee AA, Biemond I, Lamers CB (1997) Gallbladder motility and cholecystokinin secretion during continuous enteral nutrition. Am J Gastroenterol 92: 2274–2279PubMedGoogle Scholar
  115. 115.
    Schwartz TW (1983) Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85: 1411–1425PubMedGoogle Scholar
  116. 116.
    Jain MR, Pu S, Kalra PS, Kalra SP (1999) Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors. Endocrinology 140: 5171–5177CrossRefPubMedGoogle Scholar
  117. 117.
    Voisin T, Goumain M, Lorinet AM, Maoret JJ, Laburthe M (2000) Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization. J Pharmacol Exp Ther 292: 638–646PubMedGoogle Scholar
  118. 118.
    Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL et al. (1996) A receptor subtype involved in neuropeptide Y-induced food intake. Nature 382: 168–171CrossRefPubMedGoogle Scholar
  119. 119.
    Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J et al. (1996) Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271: 26315–26319PubMedGoogle Scholar
  120. 120.
    Herzog H, Darby K, Ball H, Hort Y, Beck-Sickinger A, Shine J (1997) Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation. Genomics 41: 315–319CrossRefPubMedGoogle Scholar
  121. 121.
    Borowsky B, Walker MW, Bard J, Weinshank RL, Laz TM, Vaysse P, Branchek TA, Gerald C (1998) Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs. Regul Pept 75–76: 45–53PubMedGoogle Scholar
  122. 122.
    Nakamura M, Yokoyama M, Watanabe H, Matsumoto T (1997) Molecular cloning, organization and localization of the gene for the mouse neuropeptide Y–Y5 receptor. Biochim Biophys Acta 1328: 83–89PubMedGoogle Scholar
  123. 123.
    Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, Aubert ML (2001) Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol 185: 195–204CrossRefPubMedGoogle Scholar
  124. 124.
    Guo H, Castro PA, Palmiter RD, Baraban SC (2002) Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus. J Neurophysiol 87: 558–566PubMedGoogle Scholar
  125. 125.
    Matsumoto S, Basil J, Jetton AE, Lehman MN, Bittman EL (1996) Regulation of the phase and period of circadian rhythms restored by suprachiasmatic transplants. J Biol Rhythms 11: 145–162PubMedGoogle Scholar
  126. 126.
    Moser C, Bernhardt G, Michel J, Schwarz H, Buschauer A (2000) Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells. Can J Physiol Pharmacol 78: 134–142CrossRefPubMedGoogle Scholar
  127. 127.
    Parker SL, Parker MS, Buschauer A, Balasubramaniam A (2003) Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides. Eur J Pharmacol 474: 31–42CrossRefPubMedGoogle Scholar
  128. 128.
    Du P, Salon JA, Tamm JA, Hou C, Cui W, Walker MW, Adham N, Dhanoa DS, Islam I, Vaysse PJ et al. (1997) Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Protein Eng 10: 109–117PubMedGoogle Scholar
  129. 129.
    Sylte I, Andrianjara CR, Calvet A, Pascal Y, Dahl SG (1999) Molecular dynamics of NPY Y1 receptor activation. Bioorg Med Chem 7: 2737–2748PubMedGoogle Scholar
  130. 130.
    Berglund MM, Fredriksson R, Salaneck E, Larhammar D (2002) Reciprocal mutations of neuropeptide Y receptor Y2 in human and chicken identify amino acids important for antagonist binding. FEBS Lett 518: 5–9CrossRefPubMedGoogle Scholar
  131. 131.
    Walker P, Munoz M, Martinez R, Peitsch MC (1994) Acidic residues in extracellular loops of the human Y1 neuropeptide Y receptor are essential for ligand binding. J Biol Chem 269: 2863–2869PubMedGoogle Scholar
  132. 132.
    Robin-Jagerschmidt C, Sylte I, Bihoreau C, Hendricksen L, Calvet A, Dahl SG, Benicourt C (1998) The ligand binding site of NPY at the rat Y1 receptor investigated by site-directed mutagenesis and molecular modeling. Mol Cell Endocrinol 139: 187–198CrossRefPubMedGoogle Scholar
  133. 133.
    Stenkamp RE, Filipek S, Driessen CA, Teller DC, Palczewski K (2002) Crystal structure of rhodopsin: a template for cone visual pigments and other G protein-coupled receptors. Biochim Biophys Acta 1565: 168–182PubMedGoogle Scholar
  134. 134.
    Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289: 739–745CrossRefPubMedGoogle Scholar
  135. 135.
    Eriksson H, Berglund MM, Holmberg SK, Kahl U, Gehlert DR, Larhammar D (1998) The cloned guinea pig pancreatic polypeptide receptor Y4 resembles more the human Y4 than does the rat Y4. Regul Pept 75–76: 29–37PubMedGoogle Scholar
  136. 136.
    Beck-Sickinger AG, Jung G (1995) Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Biopolymers 37: 123–142CrossRefPubMedGoogle Scholar
  137. 137.
    Danho W, Triscari J, Vincent G, Nakajima T, Taylor J, Kaiser ET (1988) Synthesis and biological evaluation of pNPY fragments. Int J Pept Protein Res 32: 496–505PubMedGoogle Scholar
  138. 138.
    Rist B, Wieland HA, Willim KD, Beck-Sickinger AG (1995) A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J Pept Sci 1: 341–348PubMedGoogle Scholar
  139. 139.
    Kirby DA, Koerber SC, Craig AG, Feinstein RD, Delmas L, Brown MR, Rivier JE (1993) Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues. J Med Chem 36: 385–393PubMedGoogle Scholar
  140. 140.
    Beck-Sickinger AG, Wieland HA, Wittneben H, Willim KD, Rudolf K, Jung G (1994) Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Eur J Biochem 225: 947–958CrossRefPubMedGoogle Scholar
  141. 141.
    Potter EK, Fuhlendorff J, Schwartz TW (1991) [Pro34]neuropeptide Y selectively identifies postjunctional-mediated actions of neuropeptide Y in vivo in rats and dogs. Eur J Pharmacol 193: 15–19CrossRefPubMedGoogle Scholar
  142. 142.
    Soll RM, Dinger MC, Lundell I, Larhammer D, Beck-Sickinger AG (2001) Novel analogues of neuropeptide Y with a preference for the Y1-receptor. Eur J Biochem 268: 2828–2837CrossRefPubMedGoogle Scholar
  143. 143.
    Hoffmann S, Rist B, Videnov G, Jung G, Beck-Sickinger AG (1996) Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist. Regul Pept 65: 61–70CrossRefPubMedGoogle Scholar
  144. 144.
    Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M, Wienen W, Beck-Sickinger AG, Doods HN (1994) The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol 271: R11–13CrossRefPubMedGoogle Scholar
  145. 145.
    Serradeil-Le Gal C, Valette G, Rouby PE, Pellet A, Oury-Donat F, Brossard G, Lespy L, Marty E, Neliat G, de Cointet P et al. (1995) SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist. FEBS Lett 362: 192–196CrossRefPubMedGoogle Scholar
  146. 146.
    Fournier A, Gagnon D, Quirion R, Cadieux A, Dumont Y, Pheng LH, St-Pierre S (1994) Conformational and biological studies of neuropeptide Y analogs containing structural alterations. Mol Pharmacol 45: 93–101PubMedGoogle Scholar
  147. 147.
    Beck A, Jung G, Gaida W, Koppen H, Lang R, Schnorrenberg G (1989) Highly potent and small neuropeptide Y agonist obtained by linking NPY 1–4 via spacer to alpha-helical NPY 25–36. FEBS Lett 244: 119–122CrossRefPubMedGoogle Scholar
  148. 148.
    Keire DA, Mannon P, Kobayashi M, Walsh JH, Solomon TE, Reeve JR, Jr, (2000) Primary structures of PYY, [Pro(34)]PYY, and PYY-(3–36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol 279: G126–131PubMedGoogle Scholar
  149. 149.
    Berglund MM, Lundell I, Eriksson H, Soll R, Beck-Sickinger AG, Larhammar D (2001) Studies of the human, rat, and guinea pig Y4 receptors using neuropeptide Y analogues and two distinct radioligands. Peptides 22: 351–356CrossRefPubMedGoogle Scholar
  150. 150.
    Walker MW, Smith KE, Bard J, Vaysse PJ, Gerald C, Daouti S, Weinshank RL, Branchek TA (1997) A structure-activity analysis of the cloned rat and human Y4 receptors for pancreatic polypeptide. Peptides 18: 609–612CrossRefPubMedGoogle Scholar
  151. 151.
    Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffman JA, Smiley DL, Chance RE, Lundell I, Larhammar D (1996) Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol 50: 112–118PubMedGoogle Scholar
  152. 152.
    Lundell I, Eriksson H, Marklund U, Larhammar D (2001) Cloning and characterization of the guinea pig neuropeptide Y receptor Y5. Peptides 22: 357–363CrossRefPubMedGoogle Scholar
  153. 153.
    Cabrele C, Beck-Sickinger AG (2000) Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci 6: 97–122PubMedGoogle Scholar
  154. 154.
    Parker EM, Balasubramaniam A, Guzzi M, Mullins DE, Salisbury BG, Sheriff S, Witten MB, Hwa JJ (2000) [D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake. Peptides 21: 393–399CrossRefPubMedGoogle Scholar
  155. 155.
    Cabrele C, Wieland HA, Koglin N, Stidsen C, Beck-Sickinger AG (2002) Ala31-Aib32: identification of the key motif for high affinity and selectivity of neuropeptide Y at the Y5-receptor. Biochemistry 41: 8043–8049CrossRefPubMedGoogle Scholar
  156. 156.
    Sautel M, Rudolf K, Wittneben H, Herzog H, Martinez R, Munoz M, Eberlein W, Engel W, Walker P, Beck-Sickinger AG (1996) Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Mol Pharmacol 50: 285–292PubMedGoogle Scholar
  157. 157.
    Munch G, Walker P, Shine J, Herzog H (1995) Ligand binding analysis of human neuropeptide Y1 receptor mutants expressed in E. coli. Receptors Channels 3: 291–297PubMedGoogle Scholar
  158. 158.
    Kannoa T, Kanatani A, Keen SL, Arai-Otsuki S, Haga Y, Iwama T, Ishihara A, Sakuraba A, Iwaasa H, Hirose M et al. (2001) Different binding sites for the neuropeptide Y Y1 antagonists 1229U91 and J-104870 on human Y1 receptors. Peptides 22: 405–413CrossRefPubMedGoogle Scholar
  159. 159.
    Sautel M, Martinez R, Munoz M, Peitsch MC, Beck-Sickinger AG, Walker P (1995) Role of a hydrophobic pocket of the human Y1 neuropeptide Y receptor in ligand binding. Mol Cell Endocrinol 112: 215–222CrossRefPubMedGoogle Scholar
  160. 160.
    Sheikh SP, Williams JA (1990) Structural characterization of Y1 and Y2 receptors for neuropeptide Y and peptide YY by affinity cross-linking. J Biol Chem 265: 8304–8310PubMedGoogle Scholar
  161. 161.
    Sheikh SP, Hansen AP, Williams JA (1991) Solubilization and affinity purification of the Y2 receptor for neuropeptide Y and peptide YY from rabbit kidney. J Biol Chem 266: 23959–23966PubMedGoogle Scholar
  162. 162.
    Wimalawansa SJ (1995) Purification and biochemical characterization of neuropeptide Y2 receptor. J Biol Chem 270: 18523–18530PubMedGoogle Scholar
  163. 163.
    Hansen AP, Sheikh SP (1992) Y2 receptor proteins for peptide YY and neuropeptide Y. Characterization as N-linked complex glycoproteins. FEBS Lett 306: 147–150CrossRefPubMedGoogle Scholar
  164. 164.
    Berglund MM, Schober DA, Esterman MA, Gehlert DR (2003) Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 307: 1120–1126CrossRefPubMedGoogle Scholar
  165. 165.
    Fabre C, el Battari A, Karamanos Y, Couvineau A, Salomon R, Laburthe M, Marvaldi J, Pichon J, Luis J (1993) Glycosylation of VIP receptors: a molecular basis for receptor heterogeneity. Peptides 14: 483–489PubMedGoogle Scholar
  166. 166.
    Holliday ND, Cox HM (2003) Control of signalling efficacy by palmitoylation of the rat Y1 receptor. Br J Pharmacol 139: 501–512CrossRefPubMedGoogle Scholar
  167. 167.
    Dinger MC, Bader JE, Kobor AD, Kretzschmar AK, Beck-Sickinger AG (2003) Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem 278: 10562–10571CrossRefPubMedGoogle Scholar
  168. 168.
    Hansen JL, Sheikh SP (2004) Functional consequences of 7TM receptor dimerization. Eur J Pharm Sci 23: 301–317PubMedGoogle Scholar
  169. 169.
    Angers S, Salahpour A, Bouvier M (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42: 409–435CrossRefPubMedGoogle Scholar
  170. 170.
    Lee SP, O’Dowd BF, George SR (2003) Homo-and hetero-oligomerization of G protein-coupled receptors. Life Sci 74: 173–180PubMedGoogle Scholar
  171. 171.
    Latif R, Graves P, Davies TF (2002) Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J Biol Chem 277: 45059–45067CrossRefPubMedGoogle Scholar
  172. 172.
    Trettel F, Di Bartolomeo S, Lauro C, Catalano M, Ciotti MT, Limatola C (2003) Ligand-independent CXCR2 dimerization. J Biol Chem 278: 40980–40988CrossRefPubMedGoogle Scholar
  173. 173.
    Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271: 16384–16392CrossRefPubMedGoogle Scholar
  174. 174.
    Canals M, Burgueno J, Marcellino D, Cabello N, Canela EI, Mallol J, Agnati L, Ferre S, Bouvier M, Fuxe K et al. (2004) Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Neurochem 88: 726–734CrossRefPubMedGoogle Scholar
  175. 175.
    Hurtley SM, Helenius A (1989) Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol 5: 277–307CrossRefPubMedGoogle Scholar
  176. 176.
    Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4: 181–191CrossRefPubMedGoogle Scholar
  177. 177.
    Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC (2000) Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers. J Biol Chem 275: 7862–7869CrossRefPubMedGoogle Scholar
  178. 178.
    Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97: 3684–3689CrossRefPubMedGoogle Scholar
  179. 179.
    Cvejic S, Devi LA (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272: 26959–26964CrossRefPubMedGoogle Scholar
  180. 180.
    Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, Jockers R (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277: 21522–21528CrossRefPubMedGoogle Scholar
  181. 181.
    Overton MC, Blumer KJ (2000) G-protein-coupled receptors function as oligomers in vivo. Curr Biol 10: 341–344CrossRefPubMedGoogle Scholar
  182. 182.
    Halazy S, Perez M, Fourrier C, Pallard I, Pauwels PJ, Palmier C, John GW, Valentin JP, Bonnafous R, Martinez J (1996) Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists. J Med Chem 39: 4920–4927CrossRefPubMedGoogle Scholar
  183. 183.
    Carrithers MD, Lerner MR (1996) Synthesis and characterization of bivalent peptide ligands targeted to G-protein-coupled receptors. Chem Biol 3: 537–542CrossRefPubMedGoogle Scholar
  184. 184.
    Duthey B, Caudron S, Perroy J, Bettler B, Fagni L, Pin JP, Prezeau L (2002) A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor. J Biol Chem 277: 3236–3241CrossRefPubMedGoogle Scholar
  185. 185.
    Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY et al. (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396: 674–679PubMedGoogle Scholar
  186. 186.
    Daniels AJ, Matthews JE, Slepetis RJ, Jansen M, Viveros OH, Tadepalli A, Harrington W, Heyer D, Landavazo A, Leban JJ et al. (1995) High-affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA 92: 9067–9071PubMedGoogle Scholar
  187. 187.
    Matthews JE, Jansen M, Lyerly D, Cox R, Chen WJ, Koller KJ, Daniels AJ (1997) Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors. Regul Pept 72: 113–119CrossRefPubMedGoogle Scholar
  188. 188.
    Selvin PR (1995) Fluorescence resonance energy transfer. Methods Enzymol 246: 300–334PubMedGoogle Scholar
  189. 189.
    Kroeger KM, Eidne KA (2004) Study of G-protein-coupled receptor-protein interactions by bioluminescence resonance energy transfer. Methods Mol Biol 259: 323–333PubMedGoogle Scholar
  190. 190.
    Xu Y, Piston DW, Johnson CH (1999) A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci USA 96: 151–156PubMedGoogle Scholar
  191. 191.
    Brady AE, Limbird LE (2002) G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell Signal 14: 297–309CrossRefPubMedGoogle Scholar
  192. 192.
    Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA, Watts E, Kerby J, Heald A, Beer M et al. (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem 277: 15482–15485CrossRefPubMedGoogle Scholar
  193. 193.
    Devi LA (2001) Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci 22: 532–537CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2006

Authors and Affiliations

  • Nicole Merten
    • 1
  • Annette G. Beck-Sickinger
    • 1
  1. 1.Institute of BiochemistryLeipzigGermany

Personalised recommendations